Gonal-F 300 IE/0.5 ml Noregur - norska - Statens legemiddelverk

gonal-f 300 ie/0.5 ml

orifarm as - follitropin alfa - injeksjonsvæske, oppløsning i ferdigfylt penn - 300 ie/0.5 ml

Gonal-F 900 IE/1.5 ml Noregur - norska - Statens legemiddelverk

gonal-f 900 ie/1.5 ml

orifarm as - follitropin alfa - injeksjonsvæske, oppløsning i ferdigfylt penn - 900 ie/1.5 ml

Mifegyne 200 mg Noregur - norska - Statens legemiddelverk

mifegyne 200 mg

exelgyn - mifepriston - tablett - 200 mg

Rekovelle 72 mikrog/2.16 ml Noregur - norska - Statens legemiddelverk

rekovelle 72 mikrog/2.16 ml

2care4 aps - follitropin delta - injeksjonsvæske, oppløsning - 72 mikrog/2.16 ml

Halagon Evrópusambandið - norska - EMA (European Medicines Agency)

halagon

emdoka bvba - halofuginon laktat - halofuginone, andre antiprotozoal agenter - kalver, nyfødte - hos nyfødte kalver:forebygging av diaré på grunn av diagnostisert cryptosporidium parvum infeksjon, i gårder med historie cryptosporidiosis. administrasjonen skal starte i de første 24 til 48 timer. reduksjon av diaré på grunn av diagnostisert cryptosporidium parvum infeksjon. administrasjon skal starte innen 24 timer etter at diaréen har begynt. i begge tilfeller har reduksjonen av oocystsekresjon blitt påvist.

Firmagon Evrópusambandið - norska - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostata neoplasmer - endokrin terapi - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Hydrocortisone aceponate Ecuphar (previously Cortacare) Evrópusambandið - norska - EMA (European Medicines Agency)

hydrocortisone aceponate ecuphar (previously cortacare)

ecuphar - hydrokortisonacceponat - kortikosteroider, dermatologiske preparater - hunder - for symptomatisk behandling av inflammatoriske og pruritiske dermatoser hos hunder. for alleviation of clinical signs associated with atopic dermatitis in dogs.

Kineret Evrópusambandið - norska - EMA (European Medicines Agency)

kineret

swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - immunsuppressive - rheumatoid arthritis (ra)kineret is indicated in adults for the treatment of the signs and symptoms of ra in combination with methotrexate, with an inadequate response to methotrexate alone. covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml. periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret bør gis i kombinasjon med colchicine, hvis det er aktuelt. still’s diseasekineret is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of still’s disease, including systemic juvenile idiopathic arthritis (sjia) and adult-onset still’s disease (aosd), with active systemic features of moderate to high disease activity, or in patients with continued disease activity after treatment with non-steroidal anti-inflammatory drugs (nsaids) or glucocorticoids. kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).

Ceretec - Noregur - norska - Statens legemiddelverk

ceretec -

ge healthcare as - eksametazim - preparasjonssett til radioaktive legemidler

Sodium Iodide [131I] Capsules T Curiumpharma - Noregur - norska - Statens legemiddelverk

sodium iodide [131i] capsules t curiumpharma -

curium netherlands b.v. - natriumjodid (131i) - kapsel, hard